Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes Among U.S. Adults by Carson, April P. et al.
Comparison of A1C and Fasting Glucose
Criteria to Diagnose Diabetes Among
U.S. Adults
APRIL P. CARSON, PHD
1
KRISTI REYNOLDS, PHD
2 VIVIAN A. FONSECA, MD
3
PAUL MUNTNER, PHD
1
OBJECTIVE — TocompareA1CandfastingglucoseforthediagnosisofdiabetesamongU.S.
adults.
RESEARCHDESIGNANDMETHODS — Thisstudyincluded6,890adults(20years
of age) from the 1999–2006 National Health and Nutrition Examination Survey without a
self-reported history of diabetes who had fasted 9h .A 1 C6.5% and fasting glucose 126
mg/dl were used, separately, to deﬁne diabetes.
RESULTS — Overall, 1.8% of U.S. adults had A1C 6.5% and fasting glucose 126 mg/dl,
0.5% had A1C 6.5% and fasting glucose 126 mg/dl, and 1.8% had A1C 6.5% and fasting
glucose 126 mg/dl. Compared with individuals with A1C 6.5% and fasting glucose 126
mg/dl, individuals with A1C 6.5% and fasting glucose 126 mg/dl were younger, more likely
to be non-Hispanic black, had lower Hb levels, and had higher C-reactive protein.
CONCLUSIONS — A1C 6.5% demonstrates reasonable agreement with fasting glucose
for diagnosing diabetes among U.S. adults.
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I
n June 2009, the International Expert
Committee released a report that rec-
ommended the use of A1C to diagnose
diabetes (1). Previously, A1C had been
used primarily to monitor glycemic con-
trol among individuals with diabetes.
However, over the last decade, the A1C
measurement has become standardized
(2,3), facilitating its recognition as an ac-
ceptable diagnostic method for diabetes.
Before the release of this report, dia-
betes was mainly deﬁned using a fasting
plasma glucose 126 mg/dl (7.0
mmol/l) in the U.S (4). Using A1C
(6.5%) to diagnose diabetes may iden-
tify different individuals than fasting
plasma glucose because the two methods
assess different elements of glucose me-
tabolism (1). The purpose of this study
was to compare A1C 6.5% and fasting
plasma glucose 126 mg/dl for the iden-
tiﬁcation of undiagnosed diabetes among
participants in the U.S. National Health
and Nutrition Examination Survey
(NHANES). Additionally, we calculated
the demographic characteristics and car-
diovascular risk proﬁle for individuals di-
agnosed with diabetes by each of these
methods.
RESEARCH DESIGN AND
METHODS— NHANES 1999–2000,
2001–2002, 2003–2004, and 2005–
2006 are serial cross-sectional surveys in-
cluding nationally representative samples
of the noninstitutionalized civilian U.S.
populationidentiﬁedthroughastratiﬁed,
multistage probability sampling design.
Methods for pooling these datasets have
been published (5). The current analysis
was limited to 6,890 participants without
self-reported diabetes who attended a
morning examination, fasted for 9ha t
thetimeoftheirbloodcollection,andhad
valid plasma glucose and A1C values.
Data were collected through ques-
tionnaires (demographics, medical his-
tory), a physical examination (blood
pressure), and blood collection (lipids,
plasma glucose, A1C). Plasma glucose
was measured using a modiﬁed hexoki-
nase enzymatic method and A1C using
high-performance liquid chromatogra-
phy.Thecoefﬁcientofvariationwas3%
in each 2-year period for glucose and
2% for A1C.
Participants were categorized into
one of four mutually exclusive groups by
the presence or absence of fasting plasma
glucose 126 mg/dl and A1C 6.5%.
The distribution of the population into
these groupings was determined. The 
statistic was calculated as a measure of
agreement. Characteristics of the study
population were calculated for each
group with the statistical signiﬁcance of
differences determined using least
squares and maximum likelihood estima-
tion for continuous and categorical vari-
ables,respectively.Insecondaryanalyses,
the distribution of U.S. adults by fasting
glucose and different A1C cut-points
(6.0–6.7%) were calculated. Also, sensi-
tivity, speciﬁcity, positive and negative
predictive values, and number of U.S.
adults misclassiﬁed were calculated using
different A1C cut-points. Analyses were
weightedtorepresenttheU.S.population
and conducted using SUDAAN (version
9; Research Triangle Institute) to account
for the complex survey design.
RESULTS— Among U.S. adults, the
prevalence of undiagnosed diabetes was
2.3% using A1C and 3.6% using fasting
glucose. Moderate agreement existed for
A1C and fasting glucose diagnoses (
0.60; 95% CI 0.55–0.64). Diabetes clas-
siﬁcation was consistent for the majority
of the study participants, with 95.9%
classiﬁed as not having diabetes by both
A1C and fasting glucose and 1.8% classi-
ﬁed as having diabetes by both A1C and
fastingglucose(Table1).Discordantclas-
siﬁcations occurred for 0.5% of partici-
pantswhohadanA1C6.5%andfasting
glucose 126 mg/dl and for 1.8% who
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126 mg/dl. Among individuals with an
A1C 6.5% and fasting glucose 126
mg/dl, 82% had impaired fasting glucose
(100–125 mg/dl). Among individuals
with an A1C 6.5% and a fasting glucose
126 mg/dl, 45% had an A1C value
6.0% but 6.5% (i.e., elevated risk for
diabetes using the new A1C guidelines).
The demographic and cardiovascular
proﬁle differed for participants with A1C
6.5% and fasting glucose 126 mg/dl
compared with individuals with A1C
6.5% and fasting glucose 126 mg/dl.
Speciﬁcally, participants with A1C
6.5% and fasting glucose 126 mg/dl
were younger, more likely to be non-
Hispanicblack,hadlowerHb,andhigher
C-reactive protein values.
The distribution of adults by fasting
glucose and different A1C cut points are
available in Table S1 (which is located in
an online-only appendix at http://care.
diabetesjournals.org/cgi/content/full/dc09-
1227/DC1). Overall, lower A1C cut points
resulted in higher sensitivity and lower
speciﬁcity (Table S2).
CONCLUSIONS— Theresultsofthe
current study indicate the new recom-
mendation by the International Expert
Committee to use A1C to diagnose diabe-
tes would result in the same classiﬁcation
as fasting glucose for 97.7% of U.S.
adults. For those with discordant results,
0.5% of U.S. adults had A1C 6.5% and
fasting glucose 126 mg/dl, whereas
1.8%hadA1C6.5%andfastingglucose
126 mg/dl. Discordance in the diagno-
sis of diabetes using A1C and fasting glu-
cose was expected and is likely due to the
assessment of different aspects of glucose
metabolism (1). For example, partici-
pants with an A1C 6.5% and fasting
glucose 126 mg/dl may have been diag-
nosed by an oral glucose tolerance test,
which was not available for the majority
of participants in this study.
About 1.8% of U.S. adults had A1C
6.5% and fasting glucose 126 mg/dl
and would not be classiﬁed as having di-
abetes using the new recommendation.
However, as deﬁned using the report’s
guidelines, almost half of these individu-
als would be identiﬁed as high risk for
diabetes based on A1C values between
6.0 and 6.4%. Although these adults
would not satisfy the new A1C recommen-
dation for the diagnosis of diabetes, they
would be targeted for preventive therapy to
reduce diabetes risk, which may also
prompt a fasting glucose measurement. Us-
ing a lower A1C cut point would result in
more diabetes diagnoses among this group;
however, there would also be a tradeoff
with substantially more diabetes diagnoses
among individuals who would have previ-
ously been classiﬁed as not having diabetes
using fasting glucose alone.
Subgroup differences were noted in
this study, with a higher percentage of in-
dividuals diagnosed with diabetes via
Table 1—Characteristics of NHANES participants (1999–2006) without self-reported diabetes, by A1C and fasting plasma glucose
A1C 6.5% A1C 6.5%
FPG
126 mg/dl
FPG
126 mg/dl
FPG
126 mg/dl
FPG
126 mg/dl
n 6,541 142 45 162
Prevalence (95% CI) 95.9 (95.3–96.5) 1.8 (1.5–2.2) 0.5 (0.4–0.7) 1.8 (1.5–2.1)
Age (years) 44.7  0.4† 60.0  1.6* 53.1  2.7 57.2  1.5
Women (%) 52.9 36.3 39.8 38.7
Race/ethnicity
Non-Hispanic white (%) 76.2* 81.9 64.9 59.5
Non-Hispanic black (%) 10.7† 7.4‡ 25.9 14.9
Hispanic (%) 13.0 10.6 9.3 25.6
Current smoker (%) 23.8 15.1 16.5 22.8
Systolic blood pressure (mmHg) 121.3  0.3 137.6  1.9 130.0  4.5 132.3  2.6
Diastolic blood pressure (mmHg) 71.1  0.3 72.0  1.4 75.8  3.7 71.2  1.7
Hypertension (%) 25.3 65.2 52.7 56.7
BMI (kg/m
2) 27.9  0.1* 31.2  0.6 34.1  2.5 32.7  0.8
Waist circumference (cm) 95.5  0.3* 107.5  1.2 112.9  6.5 110.1  1.6
Total cholesterol (mg/dl) 200.9  0.8 198.8  4.8 196.5  6.7 215.2  5.7
HDL cholesterol (mg/dl) 53.4  0.3 49.1  1.3 47.7  3.7 44.3  1.1
Triglycerides (mg/dl)§ 112 (78–164) 147 (106–214) 127 (88–151) 178 (128–257)‡
Estimated glomerular ﬁltration rate
60 ml/min per 1.73 m
2 7.4 21.6 17.0 15.6
Microalbuminuria (%) 7.0 24.2 14.7 29.6
Hb (g/dl) 14.6  0.1 15.0  0.2† 14.3  0.2 15.1  0.1†
Serum albumin (g/dl) 4.29  0.01 4.25  0.04 4.17  0.08 4.18  0.03
Ferritin (ng/ml)§ 67 (31–136)† 137 (77–253) 122 (57–139) 219 (96–293)*
Aspartate aminotransferase (units/l) 24.9  0.2 28.3  1.8 30.0  3.3 27.7  1.8
Alanine aminotransferase (unites/l) 25.6  0.3† 30.7  2.0 36.2  3.7 33.6  2.6
C-reactive protein (mg/l)§ 1.9 (0.7–4.4)† 2.2 (1.2–6.2)* 4.2 (2.1–12.9) 4.1 (2.5–9.0)
FPG (mg/dl) 95.5  0.3 136.9  1.1 110.6  2.2 199.9  7.7
A1C (%) 5.26  0.01 5.82  0.05 6.92  0.14 8.34  0.19
Data are means  SE or percent, except variables denoted by §, which are medians (25th to 75th percentiles). *P  0.05; †P  0.01; ‡P  0.001 compared with
individuals with A1C 6.5% and fasting plasma glucose (FPG) 126 mg/dl (after age adjustment).
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non-Hispanic black and of younger age.
These differences are similar to previous
reports(6–8),butcautionshouldbeused
when comparing estimates across sub-
groups because of the limited sample size
in this study.
In summary, A1C may be an appro-
priatemethodfordiagnosingdiabetes,al-
though clinical implications for using
different A1C cut points warrant further
investigation.
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